Work

Abstract 1849: Dual inhibition of AURKA and ERBB overcomes resistance to PI3K/BTK/BCL2 inhibitors in marginal zone lymphoma models.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-1849

Authors: Emma Pesenti, Alberto J. Arribas, Maidel Carpio, Eleonora Cannas, Georg Bischof, Francesco Bertoni

Institutions: Institute of Oncology Research, Università della Svizzera italiana, Puma Biotechnology (United States)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148693508

Cites:

Cited by:

Related to: